FDA limits use of Regeneron and Lilly COVID antibody treatments

日本 ニュース ニュース

FDA limits use of Regeneron and Lilly COVID antibody treatments
日本 最新ニュース,日本 見出し
  • 📰 axios
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 63%

The FDA said 'data show these treatments are highly unlikely to be active' against Omicron.

Photo: Anna Moneymaker/Getty Images

Defense Secretary Lloyd Austin has placed 8,500 U.S. troops on "heightened preparedness to deploy" to eastern Europe in case NATO activates itsNo decisions have been made to actually deploy U.S. forces, but the heightened alert level will allow the military to rapidly shore up NATO's eastern flank in the event that Russia invades Ukraine. The Pentagon warned that Russia has shown "no signs of de-escalating," and continues to amass troops on Ukraine's borders.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

axios /  🏆 302. in US

日本 最新ニュース, 日本 見出し



Render Time: 2025-03-05 07:08:30